These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 29964017

  • 1. Overexpression of FGF19 alleviates hypoxia/reoxygenation-induced injury of cardiomyocytes by regulating GSK-3β/Nrf2/ARE signaling.
    Fang Y, Zhao Y, He S, Guo T, Song Q, Guo N, Yuan Z.
    Biochem Biophys Res Commun; 2018 Sep 18; 503(4):2355-2362. PubMed ID: 29964017
    [Abstract] [Full Text] [Related]

  • 2. GSKIP protects cardiomyocytes from hypoxia/reoxygenation-induced injury by enhancing Nrf2 activation via GSK-3β inhibition.
    Yan L, Cheng G, Yang G.
    Biochem Biophys Res Commun; 2020 Oct 29; 532(1):68-75. PubMed ID: 32828530
    [Abstract] [Full Text] [Related]

  • 3. PHLPP2 downregulation protects cardiomyocytes against hypoxia-induced injury through reinforcing Nrf2/ARE antioxidant signaling.
    Jin A, Li B, Li W, Xiao D.
    Chem Biol Interact; 2019 Dec 01; 314():108848. PubMed ID: 31610156
    [Abstract] [Full Text] [Related]

  • 4. Glutaredoxin 2 protects cardiomyocytes from hypoxia/reoxygenation-induced injury by suppressing apoptosis, oxidative stress, and inflammation via enhancing Nrf2 signaling.
    Li C, Xin H, Shi Y, Mu J.
    Int Immunopharmacol; 2021 May 01; 94():107428. PubMed ID: 33581580
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Overexpression of lemur tyrosine kinase-2 protects neurons from oxygen-glucose deprivation/reoxygenation-induced injury through reinforcement of Nrf2 signaling by modulating GSK-3β phosphorylation.
    Bao H, Gao M.
    Biochem Biophys Res Commun; 2020 Jan 22; 521(4):964-970. PubMed ID: 31722791
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of SETD7 protects cardiomyocytes against hypoxia/reoxygenation-induced injury through regulating Keap1/Nrf2 signaling.
    Dang Y, Ma X, Li Y, Hao Q, Xie Y, Zhang Q, Zhang F, Qi X.
    Biomed Pharmacother; 2018 Oct 22; 106():842-849. PubMed ID: 30119254
    [Abstract] [Full Text] [Related]

  • 8. Fucoxanthin Attenuates Myocardial Ischemia/Reperfusion-Induced Injury via AMPK/GSK-3β/Nrf2 Axis.
    Zhang Q, Jin A, Cheng H, Li S, Li W.
    Chem Biol Drug Des; 2024 Sep 22; 104(3):e14621. PubMed ID: 39251393
    [Abstract] [Full Text] [Related]

  • 9. Downregulation of microRNA-302b-3p relieves oxygen-glucose deprivation/re-oxygenation induced injury in murine hippocampal neurons through up-regulating Nrf2 signaling by targeting fibroblast growth factor 15/19.
    Zhang Z, Wang N, Zhang Y, Zhao J, Lv J.
    Chem Biol Interact; 2019 Aug 25; 309():108705. PubMed ID: 31199929
    [Abstract] [Full Text] [Related]

  • 10. HIPK2 overexpression relieves hypoxia/reoxygenation-induced apoptosis and oxidative damage of cardiomyocytes through enhancement of the Nrf2/ARE signaling pathway.
    Dang X, Zhang R, Peng Z, Qin Y, Sun J, Niu Z, Pei H.
    Chem Biol Interact; 2020 Jan 25; 316():108922. PubMed ID: 31837296
    [Abstract] [Full Text] [Related]

  • 11. Glutaredoxin 1 protects neurons from oxygen-glucose deprivation/reoxygenation (OGD/R)-induced apoptosis and oxidative stress via the modulation of GSK-3β/Nrf2 signaling.
    Qiu Z, Li X, Duan C, Li R, Han L.
    J Bioenerg Biomembr; 2021 Aug 25; 53(4):369-379. PubMed ID: 33956252
    [Abstract] [Full Text] [Related]

  • 12. Upregulation of Glutaredoxin 2 alleviates oxygen-glucose deprivation/reoxygenation-induced apoptosis and ROS production in neurons by enhancing Nrf2 signaling via modulation of GSK-3β.
    Wen J, Li X, Zheng S, Xiao Y.
    Brain Res; 2020 Oct 15; 1745():146946. PubMed ID: 32522629
    [Abstract] [Full Text] [Related]

  • 13. C1q/tumor necrosis factor-related protein-6 exerts protective effects on myocardial ischemia-reperfusion injury through the modulation of the Akt-GSK-3β-Nrf2 signaling cascade.
    Liang S, Han J, Cheng W, Chen X.
    Int Immunopharmacol; 2023 Feb 15; 115():109678. PubMed ID: 36634414
    [Abstract] [Full Text] [Related]

  • 14. Paraoxonase 2 protects against oxygen-glucose deprivation/reoxygenation-induced neuronal injury by enhancing Nrf2 activation via GSK-3β modulation.
    Bai J, Jia P, Zhang Y, Wang K, Wu G.
    Hum Exp Toxicol; 2021 Aug 15; 40(8):1342-1354. PubMed ID: 33624547
    [Abstract] [Full Text] [Related]

  • 15. Sulfiredoxin-1 alleviates high glucose-induced podocyte injury though promoting Nrf2/ARE signaling via inactivation of GSK-3β.
    Shen Y, Chen S, Zhao Y.
    Biochem Biophys Res Commun; 2019 Sep 03; 516(4):1137-1144. PubMed ID: 31284950
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of TGR5 alleviates myocardial ischemia/reperfusion injury via AKT/GSK-3β mediated inflammation and mitochondrial pathway.
    Li J, Cheng R, Wan H.
    Biosci Rep; 2020 Jan 31; 40(1):. PubMed ID: 31909787
    [Abstract] [Full Text] [Related]

  • 17. Upregulation of FAM129B protects cardiomyocytes from hypoxia/reoxygenation-induced injury by inhibiting apoptosis, oxidative stress, and inflammatory response via enhancing Nrf2/ARE activation.
    Zeng G, Lian C, Li W, An H, Han Y, Fang D, Zheng Q.
    Environ Toxicol; 2022 May 31; 37(5):1018-1031. PubMed ID: 34995000
    [Abstract] [Full Text] [Related]

  • 18. CaMKK2 alleviates myocardial ischemia/reperfusion injury by inhibiting oxidative stress and inflammation via the action on the AMPK-AKT-GSK-3β/Nrf2 signaling cascade.
    Li C, Hao J, Qiu H, Xin H.
    Inflamm Res; 2023 Jul 31; 72(7):1409-1425. PubMed ID: 37338678
    [Abstract] [Full Text] [Related]

  • 19. Sappanone A alleviates hypoxia/reoxygenation-induced cardiomyocytes injury through inhibition of mitochondrial apoptosis and activation of PI3K-Akt-Gsk-3β pathway.
    Shi X, Tao G, Ji L, Tian G.
    Biosci Rep; 2020 Feb 28; 40(2):. PubMed ID: 32095825
    [Abstract] [Full Text] [Related]

  • 20. Nobiletin suppresses oxidative stress and apoptosis in H9c2 cardiomyocytes following hypoxia/reoxygenation injury.
    Liu F, Zhang H, Li Y, Lu X.
    Eur J Pharmacol; 2019 Jul 05; 854():48-53. PubMed ID: 30951715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.